Moderna
MRNA
MRNA
1,006 hedge funds and large institutions have $38.4B invested in Moderna in 2023 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 330 increasing their positions, 388 reducing their positions, and 138 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,006
Holders Change
-57
Holders Change %
-5.36%
% of All Funds
16.1%
Holding in Top 10
18
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-45.45%
% of All Funds
0.29%
New
109
Increased
330
Reduced
388
Closed
138
Calls
$2.22B
Puts
$1.86B
Net Calls
+$361M
Net Calls Change
+$40.9M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$258M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$208M |
| 3 |
JPMorgan Chase & Co
New York
|
+$167M |
| 4 |
Morgan Stanley
New York
|
+$117M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$88.2M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$173M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$171M |
| 3 |
BlackRock
New York
|
-$157M |
| 4 |
Barclays
London,
United Kingdom
|
-$125M |
| 5 |
Citigroup
New York
|
-$58.4M |